Yoshimoto A - Search Results

1

Changes in angiogenic growth factor levels after gefitinib treatment in non-small cell lung cancer.

Yoshimoto A, Kasahara K, Nishio M, Hourai T, Sone T, Kimura H, Fujimura M, Nakao S. Yoshimoto A, et al. Jpn J Clin Oncol. 2005 May;35(5):233-8. doi: 10.1093/jjco/hyi074. Epub 2005 May 10. Jpn J Clin Oncol. 2005. PMID: 15886272

2

[Transient liver injury caused by gefitinib].

Yoshimoto A, Kasahara K, Kimura H, Kita T, Fujimura M, Nakao S. Yoshimoto A, et al. Nihon Kokyuki Gakkai Zasshi. 2004 Jan;42(1):56-61. Nihon Kokyuki Gakkai Zasshi. 2004. PMID: 14768365 Japanese.

3

Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: a comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastases.

Yoshimoto A, Kasahara K, Kawashima A, Fujimura M, Nakao S. Yoshimoto A, et al. Oncol Rep. 2005 Jun;13(6):1049-57. Oncol Rep. 2005. PMID: 15870920

4

EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer.

Kimura H, Kasahara K, Shibata K, Sone T, Yoshimoto A, Kita T, Ichikawa Y, Waseda Y, Watanabe K, Shiarasaki H, Ishiura Y, Mizuguchi M, Nakatsumi Y, Kashii T, Kobayashi M, Kunitoh H, Tamura T, Nishio K, Fujimura M, Nakao S. Kimura H, et al. Among authors: yoshimoto a. J Thorac Oncol. 2006 Mar;1(3):260-7. doi: 10.1016/s1556-0864(15)31577-x. J Thorac Oncol. 2006. PMID: 17409866 Free article. Clinical Trial.

5

Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines.

Yoshimoto A, Kasahara K, Saito K, Fujimura M, Nakao S. Yoshimoto A, et al. Int J Clin Oncol. 2005 Feb;10(1):58-62. doi: 10.1007/s10147-004-0432-2. Int J Clin Oncol. 2005. PMID: 15729603

6

Gastrointestinal metastases from primary lung cancer.

Yoshimoto A, Kasahara K, Kawashima A. Yoshimoto A, et al. Eur J Cancer. 2006 Dec;42(18):3157-60. doi: 10.1016/j.ejca.2006.08.030. Epub 2006 Oct 31. Eur J Cancer. 2006. PMID: 17079136

7

[Influence of smoking on longitudinal decline in one-second forced expiratory volume in clinically healthy Japanese men: a longitudinal study].

Nishitsuji M, Fujimura M, Oribe Y, Kimura H, Nomura S, Yoshimoto A, Yoshimi Y, Kita T, Yasui M, Kasahara K, Nakao S. Nishitsuji M, et al. Among authors: yoshimoto a. Nihon Kokyuki Gakkai Zasshi. 2003 Oct;41(10):691-5. Nihon Kokyuki Gakkai Zasshi. 2003. PMID: 14584387 Japanese.

8

Severe community-acquired pneumonia in an intensive care unit: risk factors for mortality.

Yoshimoto A, Nakamura H, Fujimura M, Nakao S. Yoshimoto A, et al. Intern Med. 2005 Jul;44(7):710-6. doi: 10.2169/internalmedicine.44.710. Intern Med. 2005. PMID: 16093592 Free article.

9

Pulmonary hypertension after splenectomy in hereditary stomatocytosis.

Yoshimoto A, Fujimura M, Nakao S. Yoshimoto A, et al. Am J Med Sci. 2005 Oct;330(4):195-7. doi: 10.1097/00000441-200510000-00008. Am J Med Sci. 2005. PMID: 16234613

10

Remarkable effect of gefitinib retreatment in a patient with nonsmall cell lung cancer who had a complete response to initial gefitinib.

Yoshimoto A, Inuzuka K, Kita T, Kawashima A, Kasahara K. Yoshimoto A, et al. Am J Med Sci. 2007 Apr;333(4):221-5. doi: 10.1097/MAJ.0b013e31803b8acb. Am J Med Sci. 2007. PMID: 17435415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters